Entering text into the input field will update the search result below

Vanda Pharmaceuticals EPS beats by $0.01

  • Vanda Pharmaceuticals (NASDAQ:VNDA): Q1 GAAP EPS of $0.15 beats by $0.01.
  • Revenue of $62.7M (+8.1% Y/Y)
  • Press Release

Recommended For You

More Trending News

About VNDA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VNDA--
Vanda Pharmaceuticals Inc.